Amryt’s Filsuvez Wins English Funding For Butterfly Skin Disease, Sanofi’s Dupixent Rejected In New Indication

Amryt/Chiesi’s birch bark extract gel, Filsuvez, is the first ever treatment for epidermolysis bullosa, a group of rare skin disorders, to be recommended by NICE for English reimbursement.